NCT07803185Recruiting
Evaluation of Anhedonia and Emotional Eating in Individuals Using GLP-1 Receptor Agonists
Longitudinal Evaluation of Anhedonia and Emotional Eating Behavior in Individuals Using Glucagon-Like Peptide-1 Receptor Agonists
Source: ClinicalTrials.gov · Last updated 3 Sept 2026
Brief summary (registry, in English)
This prospective observational study evaluates the longitudinal changes in anhedonia levels and emotional eating behaviors among adult individuals initiating glucagon-like peptide-1 (GLP-1) receptor agonist therapy for weight loss. Participants are assessed at baseline (treatment initiation) and after a 6-month follow-up period using standardized psychometric instruments.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 60 (estimated)
- First submitted
- 31 Aug 2026
- Start date
- Jun 2026
- Primary completion date
- Dec 2026
- Lead sponsor
- TC Erciyes University
- Diseases
- Obesity
- NCT number
- NCT07803185
What you commit to
- Study type: Observational
- Planned participants: 60
- From Jun 2026 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Cognitive, neurological, or severe psychiatric conditions preventing completion of self-report questionnaires
Other
- Use of GLP-1 receptor agonists for indications other than weight loss
- Substantial missing, inconsistent, or unverifiable questionnaire data compromising analysis integrity
- Non-participation or dropout at the 6-month follow-up evaluation
Who the study is looking for
- Age 18 years or older
- Newly initiated on GLP-1 receptor agonist treatment for weight reduction
- Willingness to participate in evaluations at baseline and at the 6-month follow-up
- Ability to read and understand Turkish and possess the cognitive capacity to answer questionnaire items
- Voluntary provision of written informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Erciyes University Medical Faculty Hospitals, Department of Endocrinology and Metabolism Coordinator of this site? Confirm its status | Kayseri | Turkey (Türkiye) | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.